EXAS

NEUTRALM&A

Exact Sciences Corporation

2026-02-23

Price

$103.39

-0.04%

Score5.5Watchlist

Signals5/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 9

Volume0.7xvs 20d avg

Analysis

Exact Sciences is currently a 'Special Situation' (Merger Arbitrage) rather than a standard technical breakout. The company is being acquired by Abbott Laboratories (ABT) for $105.00 per share in cash, and shareholders officially approved the transaction on February 20, 2026. The stock's 'Quiet Storm' and 'Steady Climb' signals are artifacts of the price being pegged to this deal level with extremely low realized volatility (2.9% annualized). The relative strength (+2.1% vs SPY) is driven by the stock's decoupling from broader market beta/geopolitical headwinds as it waits for the deal to close in Q2 2026.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSPERFECT STACKWEAK FINISH

Key Takeaways

Arbitrage Spread: Trading at $103.39 vs. $105.00 deal price implies a ~1.5% gross spread; the market is pricing in high certainty of closing.
Catalyst Cleared: Shareholder approval (Feb 20) removes the primary internal risk; the remaining hurdle is regulatory (FTC/DOJ) and customary closing conditions.
Signal Interpretation: The 'Alpha Male' signal is a false positive for a new trend but correctly identifies the stock's resilience against the 'Caution' macro regime.

← Back to 2026-02-23 View Full EXAS History →Yahoo Finance &nearr;